跳至主要内容
临床试验/EUCTR2020-001010-38-NO
EUCTR2020-001010-38-NO进行中(未招募)1 期

ORWEGIAN CORONAVIRUS DISEASE 2019 (NO COVID-19) STUDY: AN OPEN LABELED RANDOMIZED CONTROLLED PRAGMATIC TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION - NO-COVID-19

Akershus University Hospital0 个研究点目标入组 200 人开始时间: 2020年3月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Hospitalised
  • 2.Adults 18 year or older
  • 3.Moderately severe disease (NEWS score = 6)
  • 4.SARS-CoV-2 positive nasopharyngeal swab
  • 5.Signed informed consent must be obtained and documented according to ICH GCP, and national/local regulations.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 160

排除标准

  • 1.Requiring ICU admission at screening
  • 2.History of psoriasis
  • 3.Tinnitus, reduced hearing
  • 4.Visual impairment
  • 5.Known adverse reaction to hydroxychloroquine sulphate
  • 6.Pregnancy
  • 7.Prolonged QT interval (>450 ms)

研究者

发起方
Akershus University Hospital

相似试验